Who is sponsoring NCT06384742?

NCT06384742 is sponsored by Oregon State University.

What drugs are being tested in NCT06384742?

Interventions in NCT06384742: Shift Worker Intervention for Sleep Health.

What condition does NCT06384742 study?

NCT06384742 studies Shift Work Type Circadian Rhythm Sleep Disorder, Insomnia, Psychophysiological.

Is NCT06384742 still recruiting?

NCT06384742 is currently recruiting now. Last updated 2 May 2025.

Last reviewed 2025-05-02 · How we verify

NCT06384742: SWISH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shift Worker Intervention for Sleep Health

Recruiting now NA Last updated 2 May 2025

What this trial tests

NA trial testing Shift Worker Intervention for Sleep Health in Shift Work Type Circadian Rhythm Sleep Disorder in 60 participants. Currently enrolling.

Timeline

28 April 2025

Primary endpoint
30 September 2027

15 January 2028

Quick facts

Lead sponsor	Oregon State University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	28 April 2025
Primary completion	30 September 2027
Estimated completion	15 January 2028
Sites	1 location across United States

Drugs / interventions tested

Shift Worker Intervention for Sleep Health

Conditions studied

Shift Work Type Circadian Rhythm Sleep Disorder — all drugs for Shift Work Type Circadian Rhythm Sleep Disorder →
Insomnia, Psychophysiological — all drugs for Insomnia, Psychophysiological →

Sponsor

Oregon State University

Who can join

Adults 18 to 65, any sex, with Shift Work Type Circadian Rhythm Sleep Disorder or Insomnia, Psychophysiological. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to pilot test a comprehensive, personalized, media-augmented telehealth intervention ("SWISH") designed to improve sleep health among shift workers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Oregon State University trials

Trials by the same sponsor.

NCT05965609 — Optimizing Sleep Health in Nurses · NA · completed
NCT05950672 — Development and Evaluation CAT and Youth · NA · completed
NCT05482464 — Effect of Daily Consumption of Glycomacropeptide on Gut Microbiome and Blood Functional Proteome of Subjects With Irrita · NA · completed
NCT06915129 — The Effect of Galactooligosaccharides (GOS) on the Gut Microbiota of Lactose Intolerance Individuals · NA · completed
NCT04806724 — Opening the Conversation Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06384742 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oregon State University
Last refreshed: 2 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06384742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing